Exact Mass: 744.226539

Exact Mass Matches: 744.226539

Found 30 metabolites which its exact mass value is equals to given mass value 744.226539, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   
   
   

4-O-[6-acetoxy-beta-D-glucopyranosyl(1->2)-3,4-di-O-methyl-beta-D-xylopyranosyl]diphyllin|taxodiifoloside

4-O-[6-acetoxy-beta-D-glucopyranosyl(1->2)-3,4-di-O-methyl-beta-D-xylopyranosyl]diphyllin|taxodiifoloside

C36H40O17 (744.226539)


   
   
   

1,6-dihydroxy-4-methoxy-8-O-[2-(4-hydroxy-3-methoxy-E-cinnamyl)-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranosyl]-xanthone|comastomaside C

1,6-dihydroxy-4-methoxy-8-O-[2-(4-hydroxy-3-methoxy-E-cinnamyl)-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranosyl]-xanthone|comastomaside C

C35H36O18 (744.1901556)


   
   

homoeriodictyol-7-O-beta-D-apiosyl-(1?5)-beta-D-apiosyl-(1?2)-beta-D-glucoside

homoeriodictyol-7-O-beta-D-apiosyl-(1?5)-beta-D-apiosyl-(1?2)-beta-D-glucoside

C32H40O20 (744.211284)


   

Hexa-Ac-Osmanthuside E

Hexa-Ac-Osmanthuside E

C36H40O17 (744.226539)


   

3-O-beta-D-glucopyranosyl 10-acetoxyligustroside

3-O-beta-D-glucopyranosyl 10-acetoxyligustroside

C33H44O19 (744.2476674)


   

(7S*,8R*,7S*,8R*)-huazhongilexin 9-O-(2-feruloyl)-beta-D-xylopyranoside

(7S*,8R*,7S*,8R*)-huazhongilexin 9-O-(2-feruloyl)-beta-D-xylopyranoside

C37H44O16 (744.2629224)


   

[3-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

NCGC00385587-01![3-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

C37H44O16 (744.2629224)


   

2-[[5-chloro-4-[2-chloro-4-[[1-(2,4-dimethylanilino)-1,3-dioxobutan-2-yl]diazenyl]-5-methoxyphenyl]-2-methoxyphenyl]diazenyl]-N-(2,4-dimethylphenyl)-3-oxobutanamide

2-[[5-chloro-4-[2-chloro-4-[[1-(2,4-dimethylanilino)-1,3-dioxobutan-2-yl]diazenyl]-5-methoxyphenyl]-2-methoxyphenyl]diazenyl]-N-(2,4-dimethylphenyl)-3-oxobutanamide

C38H38Cl2N6O6 (744.2229748)


   

6-methylheptyl 2-[methyl-bis[[2-(6-methylheptoxy)-2-oxoethyl]sulfanyl]stannyl]sulfanylacetate

6-methylheptyl 2-[methyl-bis[[2-(6-methylheptoxy)-2-oxoethyl]sulfanyl]stannyl]sulfanylacetate

C31H60O6S3Sn (744.2573809999999)


   
   

2,7-dimethoxy-3,6-bis(12-bromododecylthio)-naphthalene

2,7-dimethoxy-3,6-bis(12-bromododecylthio)-naphthalene

C36H58Br2O2S2 (744.2244728000001)


   

Giripladib

Giripladib

C41H36ClF3N2O4S (744.2036281999999)


C471 - Enzyme Inhibitor

   
   

Orvepitant maleate

Orvepitant maleate

C35H39F7N4O6 (744.2757678)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Orvepitant maleate (GW823296 maleate) is potent, selective, orally active and well-tolerated neurokinin-1 receptor (NK-1) antagonist with a pKi of 10.2 for human neurokinin-1 receptor. Orvepitant maleate can across the blood-brain barrier. Orvepitant maleate has the potential for depressive disorder and chronic refractory cough (CRC) treatment[1][2].

   
   
   

3,4,5-trihydroxy-6-[3-[(E)-2-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-2-carboxylic acid

3,4,5-trihydroxy-6-[3-[(E)-2-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-2-carboxylic acid

C32H40O20 (744.211284)


   

[3-Hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

[3-Hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

C37H44O16 (744.2629224)


   

(3s)-3-[(2r,3r,4s,5r,6r)-4-{[(2r,4s,5s,6s)-5-[(1s)-1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-[(acetyloxy)methyl]-3-hydroxy-5-{[(2e)-2-isothiocyanatobut-2-enoyl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

(3s)-3-[(2r,3r,4s,5r,6r)-4-{[(2r,4s,5s,6s)-5-[(1s)-1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-[(acetyloxy)methyl]-3-hydroxy-5-{[(2e)-2-isothiocyanatobut-2-enoyl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

C31H40N2O17S (744.2047590000001)